International Journal of Drug Delivery Technology
Volume 14, Issue 4

Evaluation of Hypo-glycemic and Anti-oxidant Potential of Caesalpinia sappan Leave in STZ Induced Diabetic Rats

Ahmed R1*, Jeyabalan G2, Goyal PK2

1Faculty of Pharmacy, Rajasthan University of Health Sciences, Jaipur, Rajasthan, India

2Alwar Pharmacy College, M.I.A. North Ext. Alwar, Rajasthan, India 

Received: 2nd Jul, 2024; Revised: 4th Sep, 2024; Accepted: 15th Oct, 2024; Available Online: 25th Dec, 2024 

ABSTRACT

In southern Asia, including India, Sri Lanka, and other countries, the stem bark, root, and leaves of Caesalpinia Sappan (Fabaceae) have been utilized in traditional medical systems to cure diabetes and numerous other illnesses. The hypoglycemic and hypolipidemic potential of this valued plant's leaves and bark, however, has not yet been proven by science. The current study's objective is to assess the hypoglycemic and hypolipidemic effects of Caesalpinia Sappan leaf ethanol extracts. Hydro-alcoholic extracts in dose 200mg/kg of Caesalpinia Sappan leaves (CSL) was evaluated for hypo- glycemic effect by In vitro α-amylase & α-glucosidase anti-diabetic potential similarly in vivo by using animals for 21 days in addition to the hypolipidemic potential in rats with diabetes induced by streptozotocin.The α-amylase & α-glucosidase inhibition activity was enhanced with enhanced in the concentration of extract. On administration of CSL it restored the body and organs weight. Similarly When CSL extracts were given to diabetic animal as supplements; the levels of GlyHb and plasma glucose were recovered, while insulin, C-peptide, and Hb parameters increased. In the current investigation, MDA levels were shown to be elevated; however, these levels were considerably decreased on the addition of glibenclamide and the hydro-ethanolic extract of CSL.The presence of active principles in the extract and fractions could be the cause of the observed outcome. In comparison to glibenclemide, the usual medication, the results demonstrated the potential effects of Caesalpinia Sappan leaves extract as hypoglycemic and anti-hyperlipidemic in a dose-dependent manner. Scientific evidence supports the traditional usage of this substance as an anti-diabetic.

Keywords: Caesalpinia Sappan, glibenclemide, leaves, STZ, hypoglycemic. International Journal of Drug Delivery Technology (2024);

How to cite this article: Ahmed R, Jeyabalan G, Goyal PK . Evaluation of Hypo-glycemic and Anti-oxidant potential of Caesalpinia sappan Leave in STZ Induced Diabetic Rats. International Journal of Drug Delivery Technology. 2024;14(4):1945-53 doi: 10.25258/ijddt.14.4.2

REFERENCES

  1. Abate , Chandalia M. The impact of ethnicity on type 2 diabetes. Journal of Diabetes and Its Complications 2003; 17(1):39-58. doi: 10.1016/s1056-8727(02)00190-3.
  2. Roglic WHO Global report on diabetes: A summary. International Journal of Noncommunicable Diseases Jan 2016; 1(1). doi: 10.4103/2468-8827.184853.
  3. International Diabetes Federation, Diabetes 2019, 9th ed.
  4. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and itsPart 1: diagnosis and classification of diabetes mellitus provisional reporta WHO consultation. Diabetic Medicine 998; 15(7):539-553doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID- DIA668>3.0.CO;2-S.
  5. Piero N., Nzaro G.M., Njagi J.M. Diabetes mellitus – a devastating metabolic disorder. Asian Journal of Biomedical and Pharmaceutical Sciences; 4(40):1-doi: 10.15272/ajbps.v4i40.645.
  6. Okur M.E., Karantas I.D., Siafaka P.I. Diabetes mellitus: a review on pathophysiology, current status of oral medications and future perspectives. Acta Pharmaceutica Sciencia 2017; 55(1):61-82. doi: 23893/1307-2080.APS.0555.
  7. Mitra A., Dewanjee D., Dey B. Mechanistic studies of lifestyle interventions in type 2 World Journal of Diabetes2012; 3(12):201-207. doi: 10.4239/wjd.v3.i12.201.
  8. Mamun-Rashid A., Hossain M.S., Hassan N., Sapon M.A., Sen M.K. A review on medicinal plants with antidiabetic activity. Journal of Pharmacognosy and Phytochemistry 2014; 3(4):149-159.
  9. Wadkar K., Magdum C., Patil S., Naikwade N. Antidiabetic potential and Indian medicinal plants. Journal of Herb Medicine and Toxicology 2008; 2(1):45-50.
  10. Elujoba A., Odeleye O., Ogunyemi C. Traditional medicine development for       medical       and dental primary health care delivery system in Africa. African Journal of Traditional, Complementary2005;2(1):46-61. doi: 10.4314/ajtcam.v2i1.31103.
  11. Rizvi S.I., Matteucci E., Atukeren P. Traditional medicine in management of type 2 diabetes mellitus. Journal of Diabetes Research 2013; 2013:580823. doi: 10.1155/2013/580823.
  12. Piero M.N., Joan M.N., Cromwel K.M., Joseph N.J. Hypoglycemic effects of some Kenyan plants traditionally used in management of diabetes mellitus in eastern province. Journal of Diabetes and Metabolism 2011; 2:8. doi: 10.4172/2155-6156.1000155.
  13. Wargovich J., Woods C., Hollis D.M., Zander M.E. Herbals, Cancer prevention and health.  Journal of Nutrition 2001; 131(11) Supplement 21- 22:(11suppl). doi: 10.1093/jn/131.11.3034S.
  14. Shukia , Sharma S.B., Puri D., Prabhu K.M., MurthyP.S. Medicinal plants for treatment of diabetes mellitus. Indian Journal of Clinical Biochemistry 2000; 15(1) Supplement 1:169-177. doi: 10.1007/BF02867556.
  15. Modak M., Dixit P., Londhe J., Ghaskadbi S., Devasagayam T.P.A. Indian herbs and herbal drugs used for the treatment of diabetes.Journal of Clinical Biochemistry and Nutrition 2007; 40(3):163-173. doi: 10.3164/jcbn.40.163.
  16. Suwan T., Wanachantararak P., Khongkhunthian S., Okonogi S. Antioxidant activity and potential of Caesalpinia sappan aqueous extract on synthesis of silver Drug Discoveries and Therapeutics 2018; 12(5):259-266. doi: 10.5582/ddt.2018.01059.
  17. Nigam S.S., chemical examination of the heartwood Caesalpinia sappan linn. J Res Indian Med. Yoga Homoeop 1978; 13(3):82-83.
  18. Evans C. Trease and Evans Pharmacognosy, 15th ed. New Delhi: Sounders-an imprint of Elsevier; 2002.
  19. Pandey A., Tripathi S. Concept of standardization, extraction and pre phytochemical screening strategies for herbal drug. Journal of Pharmacognosy and Phytochemistry 2014; 2(5):115-119.
  20. Harborne J.B. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis, 3rd ed., New Delhi: Springer, India; 1998.
  21. Rao S., Mohan G.K. In vitro alpha-amylase inhibition and in vivo antioxidant potential of Momordica dioica seeds in streptozotocin-induced oxidative stress in diabetic rats. Saudi Journal of Biological Sciences 2017, Sep; 24(6):1262-1267. doi: 10.1016/j.sjbs.2016.01.010.
  22. Telagari M., Hullatti K. In-vitro α-amylase and α- glucosidase inhibitory activity of Adiantum caudatum Linn. and Celosia argentea Linn. extracts and Indian Journal of Pharmacology 2015; Jul-Aug; 47(4):425-429. doi: 10.4103/0253-7613.161270.
  23. Etuk E.U. Animals models for studying diabetes mellitus. Agriculture and Biology Journal of North America 2010; 1(2):130-134.
  24. Bowe E., Franklin Z.J., Hauge-Evans A.C., King A.J., Persaud S.J., Jones P.M. Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models. Journal of Endocrinology 2014; 222(3):G13- G25. doi: 10.1530/JOE-14-0182.
  25. Guyton A.C., Hall J.E. Insulin, Glucagon and Diabetes Mellitus. Text Book of Medical Physiology, 11th ed.; 2006, 961-977.
  26. Spady D.K., Dietschy J.M. Interaction of dietary cholesterol and triglycerides in the regulation of hepaticlow density lipoprotein transport in the hamster. Journal of Clinical Investigation 1988; 81(2):300-309. doi: 10.1172/JCI113321.
  27. Rajiv Gandhi , Sasikumar P. Antidiabetic effect of Merremia emarginata Burm. F. in Streptozotocin induced diabetic rats. A. Paci. J. TropBiomedicine 2012; 2(281):286. doi: 10.1016/S2221-1691(12)60023-9.
  28. Rai P.K., Srivastava A.K., Sharma B., Dhar P., Mishra A.K., Watal G. Use of laser-induced breakdown spectroscopy for the detection of glyce- mic elements in Indian medicinal plants. Evidence-Based Complementary and Alternative Medicine: eCAM 2013; 2013:406365. doi: 10.1155/2013/406365.
  29. Watal G., Dhar P., Sharma B. Herbal medicine as an alternative medicine for  treating  diabetes: the global Evidence-Based Complementary and Alternative Medicine: eCAM 2014; 2014:1-2. doi: 10.1155/2014/596071.
  30. Hoon Jo S., Ka E., Lee H. Comparison of antioxidant potential and rat intestinal a-glucosidases inhibitory activities of quercetin, rutin, and isoquercetin. International Journal of Applied Research in Natural Products 2009; 2(4):52-60.
  31. Pupim B., Heimbürger O., Qureshi A.R., Ikizler T.A., Stenvinkel P. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney International 2005; 68(5):2368-2374. doi: 10.1111/j.1523-1755.2005.00699.x.
  32. Kamalakannan N., Ravi L., Prince P.S.M. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats. Basic and Clinical Pharmacology and Toxicology 2006; 98(1):97-103. doi: 1111/j.1742-7843.2006.pto_241.x.